Glutamine supplementation in cancer patients receiving chemotherapy: A double-blind randomized study

Federico Bozzetti; Laura Biganzoli; Cecilia Gavazzi; Federico Cappuzzo; Carlo Carnaghi; Roberto Buzzoni; Maria Di Bartolomeo; Emilio Baietta

doi:10.1016/s0899-9007(97)83038-9

JOURNAL ARTICLE

Glutamine supplementation in cancer patients receiving chemotherapy: A double-blind randomized study

Federico Bozzetti Laura Biganzoli Cecilia Gavazzi Federico Cappuzzo Carlo Carnaghi Roberto Buzzoni Maria Di Bartolomeo Emilio Baietta

Year: 1997 Journal: Nutrition Vol: 13 (7-8)Pages: 748-751 Publisher: Elsevier BV

DOI: 10.1016/s0899-9007(97)83038-9

Get Full-Text PDF Get Analytical Report

Keywords:

Glutamine Medicine Placebo Chemotherapy Diarrhea Internal medicine Breast cancer Gastroenterology Randomized controlled trial Cancer Incidence (geometry) Surgery Pathology Biology

Metrics

Cited By

1.39

FWCI (Field Weighted Citation Impact)

Refs

0.81

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Cancer, Hypoxia, and Metabolism

Life Sciences → Biochemistry, Genetics and Molecular Biology → Cancer Research

Cancer, Stress, Anesthesia, and Immune Response

Health Sciences → Medicine → Psychiatry and Mental health

Pituitary Gland Disorders and Treatments

Health Sciences → Medicine → Endocrinology, Diabetes and Metabolism

Glutamine supplementation in cancer patients receiving chemotherapy: A double-blind randomized study

Metrics

Citation History

Topics

Related Documents

O.26 Glutamine (GLN) supplementation in cancer patients receiving chemotherapy: a double blind randomized study

Randomized, Double-blind Pilot Study of Nanocurcumin in Bladder Cancer Patients Receiving Induction Chemotherapy.

Glutamine supplementation for urinary incontinence: A prospective, randomized, controlled double-blind study

Antiemetic efficacy of cimetidine randomized, double-blind, crossover study with dexamethasone in cancer patients receiving emetogenic chemotherapy

Antiemetics in children receiving cancer chemotherapy: a double-blind prospective randomized study comparing metoclopramide with chlorpromazine.